Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About IAI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Infection and Immunity
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About IAI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Bacterial Infections

Production of Stabilized Virulence Factor-Negative Variants by Group A Streptococci during Stationary Phase

B. A. B. Leonard, M. Woischnik, A. Podbielski
B. A. B. Leonard
Department of Medical Microbiology and Hygiene, University of Ulm Clinic, 89081 Ulm, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Woischnik
Department of Medical Microbiology and Hygiene, University of Ulm Clinic, 89081 Ulm, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Podbielski
Department of Medical Microbiology and Hygiene, University of Ulm Clinic, 89081 Ulm, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/IAI.66.8.3841-3847.1998
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Fig. 1.
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    Formation of stable atypical small colonies by GAS serotype M2 and M49. GAS serotypes M2 and M49 were incubated at 37°C in 5% CO2 for a number of days in THY broth without addition of fresh medium. At various days after exponential growth, aliquots were withdrawn, plated on THY agar, and incubated at 37°C in 5% CO2. The column indicated by “strain on THY” is representative of the colony dimorphism that was obtained 1 day after exponential growth and continued throughout stationary-phase incubation. To check for formation of stable atypical small isolates, representative colonies from the resulting THY plate were transferred to MH-SBA and incubated under identical conditions. The passage number is the number of times the small-colony isolates from the THY plates were sequentially passaged on MH-SBA. The results are representative of those obtained with at least three independently derived stabilized small colonies.

  • Fig. 2.
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    Growth characteristics of atypical and typical serotype M49 GAS isolates. (A) The survival of passage 3 typical and stabilized small-colony isolates was determined by inoculation of THY with a stabilized small or typical colony, followed by prolonged incubation at 37°C in 5% CO2. At approximately the same time (±3 h) on the indicated days, an aliquot was removed and dilution plated on THY agar. The number of CFU per milliliter was scored after overnight incubation at 37°C in 5% CO2. (B) Growth curves of stabilized small and typical colony isolates. THY was inoculated with passage 3 stabilized small or typical colony isolates and incubated at 37°C in 5% CO2 for 13 to 15 h. The overnight culture was then diluted 1:10, and growth was followed by measuring absorbance at 600 nm.

  • Fig. 3.
    • Open in new tab
    • Download powerpoint
    Fig. 3.

    mRNA expression of passage 3 serotype M49-derived stabilized small and typical colony isolates. mRNA was isolated from passage 3 typical and stabilized small isolates after growth in fresh medium to late logarithmic growth phase. Total RNA concentration recovered was determined by spectrophotometric measurement at OD260, appropriate dilutions were made (indicated above each lane), and even loading of the lanes was confirmed by visual inspection of eithidium bromide-stained gels prior to transfer to membranes. The RNA gels were subsequently Northern blotted, and the binding of specific DIG-labeled PCR probes (indicated below each blot) was determined by CSPD development followed by autoradiography. Fresh RNA was prepared for each blot, and the results obtained were consistent for at least two independently derived typical and stabilized small-colony isolates. Minor bands (especially predominant with the speB probe) represent mRNAs captured by the mass of 23S rRNA. The bands detected by the individual probes were consistent with reported mRNA sizes (45).

  • Fig. 4.
    • Open in new tab
    • Download powerpoint
    Fig. 4.

    Production of capsule by typical, stabilized small-colony isolates and has mutants derived from serotype M49. (A) Hyaluronic acid production of passage 3 stabilized small, typical, and M49-derived capsule synthetase mutants (has−) after overnight growth in CDM was measured by the method of Blumenkrantz and Asboe-Hansen (5). Results are reported as picograms of hyaluronic acid (pgHA) per CFU. (B) Colony morphologies of the capsule synthetase mutants and the typical and stabilized small colonies after overnight growth on MH-SBA.

  • Fig. 5.
    • Open in new tab
    • Download powerpoint
    Fig. 5.

    mRNA expression in passage 5 serotype M49-derived stabilized small and typical colony isolates. mRNA was obtained from late-logarithmic-phase cultures inoculated with passage 5 typical and stabilized small isolates when at least 50% the plated colonies had reverted to a typical large-colony phenotype. The lanes labelled “small” denote mRNA isolated from reverted stabilized small colonies. Total RNA concentration recovered was determined by spectrophotometric measurement at OD260, appropriate dilutions were made (indicated above each lane), and even loading of the lanes was confirmed by visual inspection of ethidium bromide-stained gels prior to transfer to membranes. The RNA gels were subsequently Northern blotted, and the binding of specific DIG-labeled PCR probes (indicated at the bottom of each blot) was determined by CSPD development followed by autoradiography. The bands detected by the individual probes were consistent with reported mRNA sizes (45). Fresh RNA was prepared for each blot. The autoradiograms shown above represent the consistent results obtained for the individual typical and atypical isolates at passage 5. Similar results were obtained with a second independently derived atypical small and typical isolate at passage 9.

Tables

  • Figures
  • Table 1.

    Antibiotic sensitivity of typical and atypical small colonies

    AntibioticSensitivity (μg/ml)a
    TypicalSmall
    Cefotaxime0.120.08
    Chloramphenicol3.03.0
    Clindamycin0.190.094
    Cotrimoxazole0.190.25
    Erythromycin0.0320.064
    Gentamicin4832
    Ofloxacin4.03.0
    Penicillin0.040.04
    Vancomycin1.00.75
    • ↵a Determined by the E-test according to the manufacturer’s instructions.

  • Table 2.

    Phagocytosis sensitivitya of typical and atypical small M49-derived colonies

    M49 colony typePassage no.Multiplication factor (mean ± SD)
    Typical323.6 ± 5.1
    Small30.04 ± 0.035
    Typical520.3 ± 1.45
    Small5b8.1 ± 2.5
    • ↵a Determined by the direct bactericidal assay.

    • ↵b Approximately 50% of the colonies obtained upon plating of the passage 5 small isolate had reverted to typical large colonies. Greater than >95% of the colonies recovered after the phagocytosis resistance assay formed typical-size colonies on THY plates.

PreviousNext
Back to top
Download PDF
Citation Tools
Production of Stabilized Virulence Factor-Negative Variants by Group A Streptococci during Stationary Phase
B. A. B. Leonard, M. Woischnik, A. Podbielski
Infection and Immunity Aug 1998, 66 (8) 3841-3847; DOI: 10.1128/IAI.66.8.3841-3847.1998

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Infection and Immunity article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Production of Stabilized Virulence Factor-Negative Variants by Group A Streptococci during Stationary Phase
(Your Name) has forwarded a page to you from Infection and Immunity
(Your Name) thought you would be interested in this article in Infection and Immunity.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Production of Stabilized Virulence Factor-Negative Variants by Group A Streptococci during Stationary Phase
B. A. B. Leonard, M. Woischnik, A. Podbielski
Infection and Immunity Aug 1998, 66 (8) 3841-3847; DOI: 10.1128/IAI.66.8.3841-3847.1998
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Antigens, Bacterial
Bacterial Outer Membrane Proteins
Bacterial Proteins
Carrier Proteins
Streptococcus pyogenes

Related Articles

Cited By...

About

  • About IAI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #IAIjournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0019-9567; Online ISSN: 1098-5522